Improves access to lower-cost generic and biosimilar drugs.
Reported with Assembly committee amendments Second Reading Assembly
Email me when A 1510 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 1510. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs Medicaid managed‑care organizations, the State Health Benefits Program and the School Employees Health Benefits Program to place cheaper generic and biosimilar drugs on their formularies with better cost‑sharing and without prior‑authorization hurdles. It also mandates that these plans publish up‑to‑date, easily accessible drug lists. The goal is to lower prescription costs for enrollees while preserving clinical discretion.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 1510
3 free questions a day, no accountHearings
- State and Local Government — MeetingState and Local Government · Jun 23, 2026
- Financial Institutions and Insurance — MeetingFinancial Institutions and Insurance · Jun 4, 2026
- Financial Institutions and Insurance — MeetingFinancial Institutions and Insurance · May 14, 2026
History
- Reported out of Assembly Comm. with Amendments, 2nd Reading
- Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Sponsors
- Freiman, Roy · sponsor
- Stanley, Sterley S.
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 1510 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 1510 freeOr ask your AI assistant about A 1510 directly:
Add to Claude, ChatGPT or Cursor